Close
4

Bora CDMO Bora CDMO

X

Company profile for TCR2 Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
We have built a robust pipeline of TRuC-T cell product candidates for solid and hematologic cancers. The versatility of our platform is highlighted by the multiple programs and multiple formats of the product candidates in our pipeline. In preclinical studies with TRuC-T cell product candidates, we have shown better anti-tumor activity, longer persistence, and lower cytokine release compared to CAR-T cells bearing the same...
We have built a robust pipeline of TRuC-T cell product candidates for solid and hematologic cancers. The versatility of our platform is highlighted by the multiple programs and multiple formats of the product candidates in our pipeline. In preclinical studies with TRuC-T cell product candidates, we have shown better anti-tumor activity, longer persistence, and lower cytokine release compared to CAR-T cells bearing the same tumor antigen binding domains. The FDA cleared the IND for TC-210, our lead candidate, in January 2019, and we plan to initiate TC-210’s Phase 1/2 clinical trial in early 2019.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
TCR2 Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
100 Binney Street, Suite 710 Cambridge, MA 02142
Telephone
Telephone
617.949.5200
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY